免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

CapnoSpot™ 肺氣胸解壓指示器

K 號:K223625 · 2023-03-28

決定日期2023-03-28
產品代碼GAA
諮詢委員會SU 請提供完整的描述文本,以便我進行翻譯。
決定相當於

器材摘要

CapnoSpot™ Pneumothorax Decompression Indicator is the device name listed in this FDA 510(k) record. The listed applicant is Pneumeric, Inc.. It received FDA 510(k) clearance on 2023-03-28 under 510(k) number K223625. The device is classified under product code GAA. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the CapnoSpot™ Pneumothorax Decompression Indicator?

CapnoSpot™ Pneumothorax Decompression Indicator is a medical device that received FDA 510(k) clearance on 2023-03-28. The listed applicant is Pneumeric, Inc.. The 510(k) number is K223625.

When did CapnoSpot™ Pneumothorax Decompression Indicator receive FDA 510(k) clearance?

CapnoSpot™ Pneumothorax Decompression Indicator received FDA 510(k) clearance on 2023-03-28, under 510(k) number K223625.

Who is the listed applicant for CapnoSpot™ Pneumothorax Decompression Indicator?

The FDA 510(k) record lists Pneumeric, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CapnoSpot™ Pneumothorax Decompression Indicator?

The FDA product code for CapnoSpot™ Pneumothorax Decompression Indicator is GAA.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑